Cancer care is complex and emotionally demanding not only for patients but also for clinical teams. As treatment pathways become increasingly personalised, the volume of information clinicians must gather, interpret, and act on has grown exponentially. Effective communication and timely intervention are critical to achieving the best outcomes, yet clinicians often face mounting administrative burdens that limit the time available for direct patient care.

In recent years, digital health technologies have emerged as powerful tools to bridge this communication gap. Conversational AI, in particular, offers a new way to support patients throughout their treatment journey empowering them to share how they feel, report side effects, and flag concerns between appointments. By intelligently capturing and analysing patient-reported data, these tools can help clinicians respond more efficiently and proactively, ultimately improving both patient experience and clinical outcomes.

At the forefront of this innovation is eAltra, a clinically validated conversational AI-driven digital health platform that transforms how cancer patients and their care teams communicate.

Innovative Company: eAltra

eAltra is designed to enhance cancer treatment delivery by reducing the time clinicians spend assessing patients by up to 50%. Its intelligent workflow automates toxicity screening and holistic needs assessments, streamlining data collection and easing the administrative burden on oncology teams.

Patients can access eAltra using any web-enabled device to complete toxicity assessments, patient concerns inventories, holistic needs assessments, and patient-reported outcome measures (PROMs) remotely. Before their appointment, patients receive a secure “magic-link” multi-factor login, allowing them to complete their assessments without the hassle of remembering passwords. eAltra manages the entire patient prompting cycle, ensuring assessments are completed on time and that clinicians always have up-to-date information.

For clinicians, eAltra provides an intuitive dashboard that displays patient responses in order of clinical priority, helping teams identify and address urgent needs quickly. The conversational AI interface enables patients to share information more naturally, fostering open dialogue and supporting more accurate, patient-centred care.

eAltra integrates seamlessly with electronic health records (EHRs) and supports two-way messaging between patients and clinical teams. Patients can also access tailored information and support resources at any time, ensuring they remain informed and engaged throughout their care journey.

eAltra is a participant on TheHill’s NHS Market Access Accelerator (MAA), part of the Oxford University Hospitals NHS Foundation Trust Innovation Service, which supports innovative technologies with potential to transform NHS care pathways.

To learn more about eAltra, please visit www.ealtra.com and complete the contact form.